Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB–IIA cervical cancer treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB–IIA cervical cancer treated with neoadjuvant chemotherapy

Published:2012-07 Issue:1 Volume:126 Page:140-146
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Jin LanYing,Shen Qi,Ding Shengdi,Jiang Wenxiao,Jiang Lingling,Zhu Xueqiong

Funder

National Natural Science Foundation of China

science and technology project of Zhejiang Province

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference35 articles.

1. Cervical cancer;Martin-Hirsch;Clin Evid (Online),2011

2. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages IB and II with bulky tumor;Kim;Gynecol Oncol,1989

3. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results;Sardi;Gynecol Oncol,1997

4. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer;Park;Gynecol Oncol,2004

5. II study of neoadjuvant chemotherapy with mitomycin-c vincristine and cisplatin (MVC) in patients with stages IB2–IIB cervical carcinoma;Chel Hun;Gynecol Oncol,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models;2024-07-29

2. Prognostic role of annexin A2 and cancer-associated fibroblasts in advanced non-small cell lung cancer: Implication in epithelial-mesenchymal transition and gefitinib resistance;Pathology - Research and Practice;2023-01

3. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression;Life Sciences;2022-11

4. ANXA2 is a potential marker for the diagnosis of human cervical cancer;Biomarkers in Medicine;2021-01

5. Drug resistance in gynecologic cancers: Findings and underlying mechanisms;Overcoming Drug Resistance in Gynecologic Cancers;2021